(11) 98705-3426
TrademarkIQ íconeTrademarkIQ
Voltar para busca
Dado oficial do USPTO

MEDIFORD

Sabia que essa marca já está registrada no Estados Unidos?

Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.

Active USPTO registrationTipo: MistaEscritório: US

Snapshot rápido

MEDIFORD

ST13

US500000098330501

Classe

42, 44

Pedido

98330501

Registro

7790346

Diagnóstico de risco e oportunidade

Leitura executiva para decisão de naming, protocolo e monitoramento.

Atenção: há risco ativo

Situação USPTO

Active USPTO registration

Tipo de processo

Pedido e registro

Eventos registrados

26

Atualização mais recente

22/06/2025

Classificação

Registrada

Tipo de marca

Mista

Classes Nice

42, 44

Data de depósito

26/12/2023

Data de registro

13/05/2025

Data de expiração

-

Ação recomendada

Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.

Próximo passo

Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.

Dados completos do processo

Campos estruturados da autoridade responsável e do histórico oficial.

Data da situação

13/05/2025

Última transação

22/06/2025

Escritório responsável

United States Patent and Trademark Office

Código da situação

700

Cadastro oficial

Principal Register

Fundamento do pedido

Foreign priority

Código do desenho

3

Tipo de titular

03

Localização do titular

Tokyo, JP

Examinador

BELL, MARLENE

Localização atual

FILE REPOSITORY (FRANCONIA)

Descrição da marca

The mark consists of a dark green polygon to the left of a light green hexagon, both to the left of the word MEDIFORD in gray stylized lettering.

Titulares e representantes

Titulares

M. C. (pessoa física)

Representantes

Matthew L. Frisbee LEASON ELLIS LLP

Classificação técnica

Classes Nice

Classe 42Classe 44

Códigos Vienna

Sem códigos Vienna disponíveis.

Produtos e serviços

Classe 42

testinginspection or research on pharmaceuticalscosmeticsfood additives or food including chemicals and agrochemicals for scientific research purposes; testing or research on prevention of pollution for scientific research purposes; testing of drinking water quality for scientific research purposes; environmental measurement and analysis for scientific research purposes; testing of microorganisms for scientific research purposes; environmental hygiene testing and other hygiene testing for scientific research purposes; immunologicalbiochemicalbacteriological or genetical analysistestinginspection or research relating to biological samples for scientific research purposes; analysistestinginspection or research relating to bacteriologygenetics or biotechnology for scientific research purposes; testinginspection or research on agriculturelivestock breeding or fisheries for scientific research purposes; medical testinginspection or research services for medical research purposes; scientific testingresearch or laboratory services for scientific research purposes; providing scientific advice relating to scientific testingresearch or laboratory services; scientific research in the nature of conducting clinical trials for others; medical research servicesconducting non-clinical trials relating to pharmaceuticals and medical devices; medical testinginspectionresearch or development relating to treatment or prevention of diseases for medical research purposes; medical research services; blood testing for scientific research purposes; testing and analyzing services of stoolurine and blood for scientific research purposes; clinical testing and analyzing using specimens such as bloodbodily fluidstissues extracted from human and animals for scientific research purposes; testing and analyzing services of blood and stool for clinical testing for scientific research purposes; management of clinical data of clinical trialsplanning and implementation project management of clinical trials

Classe 44

blood testing being medical analysis services for diagnostic and treatment purposes provided by medical laboratories; testing and analyzing services of stoolurine and blood being medical analysis services for diagnostic and treatment purposes provided by medical laboratories; clinical testing and analyzing of specimensbloodbodily fluidstissues extracted from human and animals for medical diagnostic and treatment purposes provided by medical laboratories; testing and analyzing services of blood and stool for clinical testing for medical diagnostic and treatment purposes provided by medical laboratories; medical analysis of clinical data of clinical trials; medical diagnostictesting and analyzing services for the diagnosis of autoimmunecardiovascularcentral nervous systemendocrinegastrointestinalgeneticimmunologicalinfectiousinflammatorymenopausalmetabolicmusculoskeletalneurodegenerativeneurologicalneuromuscularophthalmologicalpsychiatricrespiratoryurogenitaloncologicalurological and viral diseases and disordersblood disordersliver disorderserectile dysfunctionsexual dysfunctioncancerpaindiabetes; medical diagnostic services for autoimmunecardiovascularcentral nervous systemendocrinegastrointestinalgeneticimmunologicalinfectiousinflammatorymenopausalmetabolicmusculoskeletalneurodegenerativeneurologicalneuromuscularophthalmologicalpsychiatricrespiratoryurogenitaloncologicalurological and viral diseases and disordersblood disordersliver disorderserectile dysfunctionsexual dysfunctioncancerpaindiabetes; provision of medical information; medical clinical testing and medical evaluation for autoimmunecardiovascularcentral nervous systemendocrinegastrointestinalgeneticimmunologicalinfectiousinflammatorymenopausalmetabolicmusculoskeletalneurodegenerativeneurologicalneuromuscularophthalmologicalpsychiatricrespiratoryurogenitaloncologicalurological and viral diseases and disordersblood disordersliver disorderserectile dysfunctionsexual dysfunctioncancerpaindiabetes; performing medical diagnosis of diseases based on evaluation of progress of clinical trials for autoimmunecardiovascularcentral nervous systemendocrinegastrointestinalgeneticimmunologicalinfectiousinflammatorymenopausalmetabolicmusculoskeletalneurodegenerativeneurologicalneuromuscularophthalmologicalpsychiatricrespiratoryurogenitaloncologicalurological and viral diseases and disordersblood disordersliver disorderserectile dysfunctionsexual dysfunctioncancerpaindiabetes; clinical testingmedical testing services; clinical testing for use in medical treatment and medical examination services for human and animals; medical consultancy services relating to clinical tests; medical consultancy services relating to medical care; providing medical advice and information relating to clinical tests; medical and pharmaceutical consultation; medical analysis of clinical data of clinical trials

Publicações

Histórico de despachos e eventos da marca no USPTO.

26 publicações encontradas

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

17/06/2025

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

17/06/2025

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

17/06/2025

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

13/05/2025

R.PR

REGISTERED-PRINCIPAL REGISTER

13/05/2025

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

25/03/2025

PUBO

PUBLISHED FOR OPPOSITION

25/03/2025

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

19/03/2025

ERRR

ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED

27/02/2025

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

22/02/2025

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

04/02/2025

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

04/02/2025

ERFR

TEAS REQUEST FOR RECONSIDERATION RECEIVED

04/02/2025

GNFN

NOTIFICATION OF FINAL REFUSAL EMAILED

10/12/2024

GNFR

FINAL REFUSAL E-MAILED

10/12/2024

CNFR

FINAL REFUSAL WRITTEN

10/12/2024

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

18/10/2024

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

18/10/2024

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

18/10/2024

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

31/07/2024

GNRT

NON-FINAL ACTION E-MAILED

31/07/2024

CNRT

NON-FINAL ACTION WRITTEN

31/07/2024

DOCK

ASSIGNED TO EXAMINER

24/07/2024

MDSC

NOTICE OF DESIGN SEARCH CODE E-MAILED

08/04/2024

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

08/04/2024

NWAP

NEW APPLICATION ENTERED

26/12/2023

Proteção contínua da sua marca

Seja avisado a cada novo depósito que ameace MEDIFORD ou a sua marca.

Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.